Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone

Background: Pirfenidone is an anti-fibrotic agent used to treat patients with idiopathic pulmonary fibrosis (IPF). Managing adverse drug events and ensuring compliance with pirfenidone treatment for a prolonged period are important to reduce the rate of disease progression. To maximize the benefits...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Pharmacol
Päätekijät: Satsuma, Yukari, Ikesue, Hiroaki, Kusuda, Kaori, Maeda, Mami, Muroi, Nobuyuki, Mori, Ryobu, Kogo, Mariko, Hirabayashi, Ryosuke, Nagata, Kazuma, Nakagawa, Atsushi, Tachikawa, Ryo, Tomii, Keisuke, Hashida, Tohru
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7725709/
https://ncbi.nlm.nih.gov/pubmed/33324201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.529654
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia